Boxer Capital’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-75,053
| Closed | -$10.9M | – | 83 |
|
|
2021
Q3 | $10.9M | Hold |
75,053
| – | – | 0.38% | 58 |
|
|
2021
Q2 | $13.9M | Hold |
75,053
| – | – | 0.49% | 59 |
|
|
2021
Q1 | $18.5M | Hold |
75,053
| – | – | 0.63% | 46 |
|
|
2020
Q4 | $21.2M | Hold |
75,053
| – | – | 0.68% | 42 |
|
|
2020
Q3 | $18M | Buy |
75,053
+24,590
| +49% | +$5.9M | 0.62% | 39 |
|
|
2020
Q2 | $16.8M | Hold |
50,463
| – | – | 0.74% | 36 |
|
|
2020
Q1 | $11.5M | Hold |
50,463
| – | – | 0.78% | 32 |
|
|
2019
Q4 | $12.4M | Buy |
+50,463
| New | +$12.4M | 0.7% | 34 |
|
|
2018
Q2 | – | Sell |
-37,375
| Closed | -$10.5M | – | 29 |
|
|
2018
Q1 | $10.5M | Buy |
37,375
+21,750
| +139% | +$6.12M | 1.12% | 21 |
|
|
2017
Q4 | $3.68M | Hold |
15,625
| – | – | 0.67% | 22 |
|
|
2017
Q3 | $4.43M | Sell |
15,625
-10,625
| -40% | -$3.02M | 1.01% | 19 |
|
|
2017
Q2 | $7.39M | Sell |
26,250
-17,638
| -40% | -$4.96M | 1.76% | 13 |
|
|
2017
Q1 | $14.7M | Hold |
43,888
| – | – | 3.2% | 8 |
|
|
2016
Q4 | $14.5M | Hold |
43,888
| – | – | 5.61% | 6 |
|
|
2016
Q3 | $11.7M | Hold |
43,888
| – | – | 5.26% | 7 |
|
|
2016
Q2 | $5.81M | Buy |
43,888
+2,887
| +7% | +$382K | 5.15% | 9 |
|
|
2016
Q1 | $7.23M | Buy |
41,001
+530
| +1% | +$93.5K | 7.08% | 7 |
|
|
2015
Q4 | $10.1M | Buy |
+40,471
| New | +$10.1M | 8.72% | 2 |
|